Literature DB >> 21102629

Heart failure: A SHIFT from ion channels to clinical practice.

Cesare M Terracciano1, Magdi H Yacoub.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21102629     DOI： 10.1038/nrcardio.2010.179

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Ivabradine in heart failure--no paradigm SHIFT…yet.

Authors:  John R Teerlink
Journal:  Lancet       Date:  2010-09-11       Impact factor: 79.321

Review 2.  The role of the funny current in pacemaker activity.

Authors:  Dario DiFrancesco
Journal:  Circ Res       Date:  2010-02-19       Impact factor: 17.367

3.  How does adrenaline accelerate the heart?

Authors:  H F Brown; D DiFrancesco; S J Noble
Journal:  Nature       Date:  1979-07-19       Impact factor: 49.962

4.  Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.

Authors:  Michael Böhm; Karl Swedberg; Michel Komajda; Jeffrey S Borer; Ian Ford; Ariane Dubost-Brama; Guy Lerebours; Luigi Tavazzi
Journal:  Lancet       Date:  2010-09-11       Impact factor: 79.321

5.  Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Authors:  Karl Swedberg; Michel Komajda; Michael Böhm; Jeffrey S Borer; Ian Ford; Ariane Dubost-Brama; Guy Lerebours; Luigi Tavazzi
Journal:  Lancet       Date:  2010-09-11       Impact factor: 79.321

Review 6.  Contemporary use of ventricular assist devices.

Authors:  Cesare M Terracciano; Leslie W Miller; Magdi H Yacoub
Journal:  Annu Rev Med       Date:  2010       Impact factor: 13.739

7.  Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction.

Authors:  Gerd Heusch; Andreas Skyschally; Petra Gres; Patrick van Caster; Dustin Schilawa; Rainer Schulz
Journal:  Eur Heart J       Date:  2008-07-10       Impact factor: 29.983

8.  Current-dependent block of rabbit sino-atrial node I(f) channels by ivabradine.

Authors:  Annalisa Bucchi; Mirko Baruscotti; Dario DiFrancesco
Journal:  J Gen Physiol       Date:  2002-07       Impact factor: 4.086

9.  Molecular identification of a hyperpolarization-activated channel in sea urchin sperm.

Authors:  R Gauss; R Seifert; U B Kaupp
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

10.  Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Authors:  Kim Fox; Ian Ford; P Gabriel Steg; Michal Tendera; Roberto Ferrari
Journal:  Lancet       Date:  2008-08-29       Impact factor: 79.321
  10 in total
  2 in total

1.  Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression.

Authors:  S Suffredini; F Stillitano; L Comini; M Bouly; S Brogioni; C Ceconi; R Ferrari; A Mugelli; E Cerbai
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Mitochondrial KATP Channels Control Glioma Radioresistance by Regulating ROS-Induced ERK Activation.

Authors:  Lianyan Huang; Boxing Li; Shihao Tang; Hongbo Guo; Wenjun Li; Xiaozhou Huang; Wenjuan Yan; Fei Zou
Journal:  Mol Neurobiol       Date:  2014-09-24       Impact factor: 5.590
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.